Evidence map›Paper›PMID 41442200›Full record

Trial reportKidney3602026

Conservative Kidney Management Jumpstart: Designing a Behavioral Nudge to Jumpstart Conversations about Conservative Kidney Management between Patients and Nephrologists.

Susan P Y Wong, Olivia Gaughran, Deborah Lee, Jane Schell, Daniel Y Lam, Grady Paden, Erin K Kross

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05753020 (A Pilot Study of The CKM JumpStart Tool), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05753020 narecruitingnot on this map

A Pilot Study of The CKM JumpStart Tool

TypeinterventionalSponsorUniversity of WashingtonRan2023 to 2025Enrolled76ConditionsChronic Kidney DiseasesArmsCKM Jumpstart Tool
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Susan P Y WongDepartment of Medicine, University of Washington, Seattle, Washington.ORCID 0000-0002-8127-8121
Olivia GaughranDepartment of Medicine, University of Washington, Seattle, Washington.ORCID 0009-0000-9799-5021
Deborah LeeDepartment of Medicine, University of California San Francisco, San Francisco, California.
Jane SchellDepartment of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0001-7802-5791
Daniel Y LamDepartment of Medicine, University of Washington, Seattle, Washington.
Grady PadenDepartment of Medicine, University of Washington, Seattle, Washington.ORCID 0009-0002-4652-3811
Erin K KrossDepartment of Medicine, University of Washington, Seattle, Washington.ORCID 0000-0002-8206-3050

Funding

Doris Duke Charitable Foundation Clinical Scientist Development Award
6 · The paper itself

Abstract

key pointsBehavioral nudging can activate nephrologists to adopt new behaviors around discussing conservative kidney management with patients. Conservative kidney management Jumpstart is a nudge that offers nephrologists a framework and words-to-try to discuss health care values and conservative kidney management with patients. Conservative Kidney Management Jumpstart nudged nephrologists to discuss values and conservative kidney management with patients and revealed persistent challenges with these discussions.

backgroundNephrologists do not routinely discuss conservative kidney management (CKM) with their patients, hindering informed decision-making about kidney failure treatments. Nudges are interventions that facilitate behavior change and may assist nephrologists with discussing CKM.

methodsWe designed a behavioral nudge, called CKM Jumpstart, to assist nephrologists with discussing CKM with their patients. CKM Jumpstart was developed using human-centered design principles in 3 phases: ( 1 ) Discovery (March-June 2022): literature review and deliberation about the challenges to discussing CKM with an advisory panel; ( 2 ) Design (June-December 2022): multiple cycles of prototyping of CKM Jumpstart with input from the advisory panel and ten nephrologists across the United States; and ( 3 ) Implementation (April 2023-July 2025): testing a final version of CKM Jumpstart in 36 clinic visits with 19 nephrologists recruited from the greater Seattle area and conducting qualitative interviews with nephrologists about their experiences using CKM Jumpstart.

resultsIn the Discovery phase, we identified four major challenges to discussing CKM: ( 1 ) attitudes favoring dialysis as the norm; ( 2 ) lack of clarity about patients' health care values; ( 3 ) difficulty describing CKM; and, ( 4 ) fear of upsetting patients. The Design phase produced a prototype of CKM Jumpstart that addressed these challenges by providing a communication framework and example language that nephrologists could try to discuss patients' health care values and CKM. During the Implementation phase, all the nephrologists tried CKM Jumpstart at least once and were nudged to have conversations about values, CKM, and/or kidney failure treatment options more broadly. Nephrologists selectively used parts of CKM Jumpstart that suited their communication style. Some felt conversations occurred too early in patients' disease course and were uncertain about how to address conflicting values and treatment preferences.

conclusionsBehavioral nudging assists nephrologists with discussing health care values and CKM with patients. It can also reveal persistent challenges with having these discussions among nephrologists. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: A Pilot Study of The CKM JumpStart Tool, NCT05753020 .

Indexed as

Conservative TreatmentNephrologistsPhysician-Patient RelationsCommunicationHumansMaleconservative managementgeriatric nephrologypalliative care

Identifiers

PMID41442200
PMCPMC13229439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.